Literature DB >> 18400847

Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection.

Xibing Che1, Mike Reichelt, Marvin H Sommer, Jaya Rajamani, Leigh Zerboni, Ann M Arvin.   

Abstract

The gene cluster composed of varicella-zoster virus (VZV) open reading frame 9 (ORF9) to ORF12 encodes four putative tegument proteins and is highly conserved in most alphaherpesviruses. In these experiments, the genes within this cluster were deleted from the VZV parent Oka (POKA) individually or in combination, and the consequences for VZV replication were evaluated with cultured cells in vitro and with human skin xenografts in SCID mice in vivo. As has been reported for ORF10, ORF11 and ORF12 were dispensable for VZV replication in melanoma and human embryonic fibroblast cells. In contrast, deletion of ORF9 was incompatible with the recovery of infectious virus. ORF9 localized to the virion tegument and formed complexes with glycoprotein E, which is an essential protein, in VZV-infected cells. Recombinants lacking ORF10 and ORF11 (POKADelta10/11), ORF11 and ORF12 (POKADelta11/12), or ORF10, ORF11 and ORF12 (POKADelta10/11/12) were viable in cultured cells. Their growth kinetics did not differ from those of POKA, and nucleocapsid formation and virion assembly were not disrupted. In addition, these deletion mutants showed no differences compared to POKA in infectivity levels for primary human tonsil T cells. Deletion of ORF12 had no effect on skin infection, whereas replication of POKADelta11, POKADelta10/11, and POKADelta11/12 was severely reduced, and no virus was recovered from skin xenografts inoculated with POKADelta10/11/12. These results indicate that with the exception of ORF9, the individual genes within the ORF9-to-ORF12 gene cluster are dispensable and can be deleted simultaneously without any apparent effect on VZV replication in vitro but that the ORF10-to-ORF12 cluster is essential for VZV virulence in skin in vivo.

Entities:  

Mesh:

Year:  2008        PMID: 18400847      PMCID: PMC2395146          DOI: 10.1128/JVI.00303-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16.

Authors:  Fabien Dorange; Slimane El Mehdaoui; Chantal Pichon; Pierre Coursaget; Jean-François Vautherot
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

2.  Assembly of infectious Herpes simplex virus type 1 virions in the absence of full-length VP22.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice.

Authors:  R A Santos; C C Hatfield; N L Cole; J A Padilla; J F Moffat; A M Arvin; W T Ruyechan; J Hay; C Grose
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

4.  Interactions among structural proteins of varicella zoster virus.

Authors:  M Spengler; N Niesen; C Grose; W T Ruyechan; J Hay
Journal:  Arch Virol Suppl       Date:  2001

5.  Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro.

Authors:  J I Cohen; K Seidel
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network.

Authors:  A A Gershon; D L Sherman; Z Zhu; C A Gabel; R T Ambron; M D Gershon
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products.

Authors:  J A Blaho; C Mitchell; B Roizman
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

8.  Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters.

Authors:  H Moriuchi; M Moriuchi; S E Straus; J I Cohen
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression.

Authors:  Y Zhang; J L McKnight
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth.

Authors:  X Liang; B Chow; Y Li; C Raggo; D Yoo; S Attah-Poku; L A Babiuk
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  34 in total

1.  Identification and functional characterization of the Varicella zoster virus ORF11 gene product.

Authors:  Xibing Che; Stefan L Oliver; Marvin H Sommer; Jaya Rajamani; Mike Reichelt; Ann M Arvin
Journal:  Virology       Date:  2011-01-26       Impact factor: 3.616

2.  Varicella-Zoster Virus ORF9p Binding to Cellular Adaptor Protein Complex 1 Is Important for Viral Infectivity.

Authors:  Marielle Lebrun; Julien Lambert; Laura Riva; Nicolas Thelen; Xavier Rambout; Caroline Blondeau; Marc Thiry; Robert Snoeck; Jean-Claude Twizere; Franck Dequiedt; Graciela Andrei; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 3.  Vaccines: the fourth century.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

4.  Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.

Authors:  Seung-Tae Lee; Paige Bracci; Mi Zhou; Terri Rice; John Wiencke; Margaret Wrensch; Joseph Wiemels
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

Review 5.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

Review 6.  Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.

Authors:  Ann M Arvin; Jennifer F Moffat; Marvin Sommer; Stefan Oliver; Xibing Che; Susan Vleck; Leigh Zerboni; Chia-Chi Ku
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 7.  The varicella-zoster virus genome.

Authors:  Jeffrey I Cohen
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

8.  ORF11 protein interacts with the ORF9 essential tegument protein in varicella-zoster virus infection.

Authors:  Xibing Che; Stefan L Oliver; Mike Reichelt; Marvin H Sommer; Jürgen Haas; Tihana L Roviš; Ann M Arvin
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

Review 9.  Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells.

Authors:  Nandini Sen; Ann M Arvin
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

10.  Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.

Authors:  Stefan L Oliver; Marvin Sommer; Leigh Zerboni; Jaya Rajamani; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.